Preoperative Opioid Utilization Patterns and Postoperative Opioid Utilization: A Retrospective Cohort Study.
Preoperative Opioid Utilization Patterns and Postoperative Opioid Utilization: A Retrospective Cohort Study.
复制标题
DOI:
10.1097/aln.0000000000004026
复制
发表时间:
2021-12-01
期刊:
影响因子:
8.8
通讯作者:
Sun EC
中科院分区:
文献类型:
--
作者:
Rishel CA;Angst MS;Sun EC
Among chronic opioid users, the association between decreasing or increasing preoperative opioid utilization and postoperative outcomes is unknown. We hypothesized that decreasing utilization would be associated with improved outcomes and increasing utilization with worsened outcomes. Using commercial insurance claims, we identified 57,019 chronic opioid users (≥10 prescriptions or ≥120 days supplied during the preoperative year), aged 18-89 undergoing one of ten surgeries between 2004 and 2018. Patients with a ≥20% decrease or increase in opioid utilization between preoperative days 7-90 and 91-365 were compared to patients with <20% change (stable utilization). The primary outcome was opioid utilization during postoperative days 91-365. Secondary outcomes included alternative measures of postoperative opioid utilization (filling a minimum number of prescriptions during this period), postoperative adverse events, and healthcare utilization. The average age was 63 (SD 13), with 38,045 (66.7%) female patients. Preoperative opioid utilization was decreasing for 12,347 (21.7%) patients, increasing for 21,330 (37.4%) patients, and stable for 23,342 (40.9%) patients. Patients with decreasing utilization were slightly less likely to fill an opioid prescription during postoperative days 91-365 compared to stable patients (89.2% vs. 96.4%, OR 0.323, 95% CI 0.296 to 0.352, p<0.001), though the average daily doses were similar among patients who continued to utilize opioids during this timeframe (46.7 vs. 46.5 morphine milligram equivalents, difference 0.2, 95% CI −0.8 to 1.2, P=0.684). 93.6% of patients with increasing utilization filled opioid prescriptions during this period (OR 0.57, 95% CI 0.52 to 0.62, p<0.001), with slightly lower average daily doses (44.3 morphine milligram equivalents, difference −2.2, 95% CI −3.1 to −1.3, P<0.001). Except for alternative measures of persistent postoperative opioid utilization, there were no clinically significant differences for the secondary outcomes. Changes in preoperative opioid utilization were not associated with clinically significant differences for several postoperative outcomes including postoperative opioid utilization.